Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1992 2
1996 2
1997 1
1999 2
2000 2
2002 3
2003 2
2004 4
2005 3
2006 4
2007 5
2008 6
2009 7
2010 7
2011 9
2012 16
2013 11
2014 14
2015 11
2016 19
2017 20
2018 14
2019 16
2020 16
2021 15
2022 12
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Taylor PC, Bieber T, Alten R, Witte T, Galloway J, Deberdt W, Issa M, Haladyj E, De La Torre I, Grond S, Wollenberg A. Taylor PC, et al. Among authors: alten r. Adv Ther. 2023 Apr;40(4):1867-1883. doi: 10.1007/s12325-023-02445-w. Epub 2023 Feb 20. Adv Ther. 2023. PMID: 36802049 Free PMC article. Clinical Trial.
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, Östör A, Ng KJ, Gerwien J, Zaremba-Pechmann L, Brnabic AJM, Fautrel B. Alten R, et al. Rheumatol Ther. 2023 Dec;10(6):1575-1595. doi: 10.1007/s40744-023-00597-3. Epub 2023 Sep 27. Rheumatol Ther. 2023. PMID: 37755648 Free PMC article.
Macrophagic Myofasciitis.
Stenzel W, Heppner FL, Goebel HH, Alten RH. Stenzel W, et al. Among authors: alten rh. Dtsch Arztebl Int. 2009 Apr;106(14):248. doi: 10.3238/arztebl.2009.0248a. Epub 2009 Apr 3. Dtsch Arztebl Int. 2009. PMID: 19547641 Free PMC article. No abstract available.
New concepts to reduce glucocorticoid toxicity.
Alten R, Mischkewitz M. Alten R, et al. Joint Bone Spine. 2019 Nov;86(6):715-723. doi: 10.1016/j.jbspin.2018.11.006. Epub 2018 Dec 5. Joint Bone Spine. 2019. PMID: 30528678 Review.
[Genitourinary malignancies and rheumatoid arthritis].
Boegemann M, Alten R, Aringer M, Zastrow S. Boegemann M, et al. Among authors: alten r. Z Rheumatol. 2016 Feb;75(1):54-62. doi: 10.1007/s00393-015-0031-9. Z Rheumatol. 2016. PMID: 26786167 Review. German.
[Autoimmune reactions to immune checkpoint inhibitors].
Pönisch W, Alten R, Baerwald C. Pönisch W, et al. Among authors: alten r. Z Rheumatol. 2017 Oct;76(Suppl 2):57-62. doi: 10.1007/s00393-017-0368-3. Z Rheumatol. 2017. PMID: 29330759 Review. German.
Maximizing the success of biosimilar implementation.
Alten R, Weinbrecht-Mischkewitz M. Alten R, et al. Nat Rev Rheumatol. 2023 Dec;19(12):757-758. doi: 10.1038/s41584-023-01048-7. Nat Rev Rheumatol. 2023. PMID: 37903917 No abstract available.
Clinical trial development for biosimilars.
Alten R, Cronstein BN. Alten R, et al. Semin Arthritis Rheum. 2015 Jun;44(6 Suppl):S2-8. doi: 10.1016/j.semarthrit.2015.04.002. Semin Arthritis Rheum. 2015. PMID: 26058550 Free article. Review.
219 results